POTENTIAL SIDE EFFECTS BOOK NOW Mild Gastrointestinal Discomfort: Some individuals may experience temporary nausea or stomach upset as their body adjusts

Topical formulations Serum : Most common, 1-3% GHK-Cu concentration Cream : Heavier, good for dry skin, 0.5-2% concentration Patches : Copper peptide patches deliver sustained release, convenient DIY : Some make their own from powder (advanced users) Commercial products : Many skincare brands offer GHK-Cu serums Topical application Frequency : Apply 2x daily (morning and evening) Amount : 2-3 drops serum or pea-sized amount cream Application sites : Face and neck (anti-aging) Under eyes (fine lines, dark circles) Hands (age spots, wrinkles) Any area with skin concerns Process : Cleanse skin Apply to slightly damp skin Pat gently, don't rub aggressively Let absorb (2-3 minutes) Follow with moisturizer if needed Timing : Morning application + evening application for best results Topical vs injectable for skin Topical advantages : Less expensive ($30-60 per month) No injection skill needed Direct application to target area Convenient daily use Injectable advantages : Systemic benefits (not just skin) Higher bioavailability Anti-inflammatory effects throughout body Better for deep skin layers Best approach : Combine both for maximum skin results (topical + 1mg daily injectable) Expected results timeline 4-6 weeks : Improved skin texture, slight glow 8-12 weeks : Reduced fine lines, better firmness 4-6 months : Significant wrinkle reduction, improved elasticity, even tone Long-term : Continued improvement with consistent use Realistic expectations : Not Botox-level immediate results

IGF-1 LR3 vs Comparable Research Peptides IGF-1 LR3 differs from other growth-factor-related research peptides primarily in where it acts: it binds directly to the IGF-1 receptor, while several comparable compounds work upstream by stimulating the bodys own growth hormone or IGF-1 production
ATP is an important cofactor of GSH production
For patients who have been tracking the longevity medicine space who understand the difference between reactive disease management and proactive optimization this is a meaningful signal